These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2904918)

  • 1. Antipsychotic withdrawal phenomena in the medical-surgical setting.
    Dilsaver SC; Coffman JA
    Gen Hosp Psychiatry; 1988 Nov; 10(6):438-46. PubMed ID: 2904918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic withdrawal symptoms: phenomenology and pathophysiology.
    Dilsaver SC; Alessi NE
    Acta Psychiatr Scand; 1988 Mar; 77(3):241-6. PubMed ID: 2899377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterocyclic antidepressant, monoamine oxidase inhibitor and neuroleptic withdrawal phenomena.
    Dilsaver SC
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(2):137-61. PubMed ID: 1968671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal phenomena associated with antidepressant and antipsychotic agents.
    Dilsaver SC
    Drug Saf; 1994 Feb; 10(2):103-14. PubMed ID: 7912078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome after neuroleptic discontinuation.
    Amore M; Zazzeri N
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Dec; 19(8):1323-34. PubMed ID: 8868212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome precipitated by haloperidol following clozapine discontinuation.
    Mendhekar DN; Jiloha RC
    Aust N Z J Psychiatry; 2005 Oct; 39(10):947-8. PubMed ID: 16168023
    [No Abstract]   [Full Text] [Related]  

  • 7. Management of psychotic symptoms associated with the disease and its treatments.
    Monias A; Samuels SC
    Geriatrics; 2001 Nov; 56(11):56-7. PubMed ID: 11710816
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical outcome after antipsychotic treatment discontinuation in functionally recovered first-episode nonaffective psychosis individuals: a 3-year naturalistic follow-up study.
    Mayoral-van Son J; de la Foz VO; Martinez-Garcia O; Moreno T; Parrilla-Escobar M; Valdizan EM; Crespo-Facorro B
    J Clin Psychiatry; 2016 Apr; 77(4):492-500. PubMed ID: 26759992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching antipsychotics. Antipsychotic tolerance, withdrawal and relapse: unresolved issues and research implications.
    Goudie AJ; Cole JC
    J Psychopharmacol; 2008 Sep; 22(7):815-7. PubMed ID: 18753274
    [No Abstract]   [Full Text] [Related]  

  • 10. [Indications for, limitations, and hazards of neuroleptic agents].
    Hoes MJ
    Ned Tijdschr Geneeskd; 1980 Apr; 124(17):647-53. PubMed ID: 6104304
    [No Abstract]   [Full Text] [Related]  

  • 11. Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse.
    Moncrieff J
    Acta Psychiatr Scand; 2006 Jul; 114(1):3-13. PubMed ID: 16774655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyserositis, acute withdrawal, and relapse after abrupt clozapine discontinuation.
    Malhotra S; Franco K; Tomford JW; Iqbal R
    Psychosomatics; 2002; 43(5):418-20. PubMed ID: 12297612
    [No Abstract]   [Full Text] [Related]  

  • 13. Insomnia related to biperiden withdrawal in two schizophrenic patients.
    Hirose S
    Int Clin Psychopharmacol; 2000 Nov; 15(6):357-9. PubMed ID: 11110012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complications of drug withdrawal from antiparkinson agents and neuroleptics].
    Mizon JP; Rosa A
    Therapie; 1984; 39(4):421-5. PubMed ID: 6148792
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical predictors of relapse following neuroleptic withdrawal.
    Buchanan RW; Kirkpatrick B; Summerfelt A; Hanlon TE; Levine J; Carpenter WT
    Biol Psychiatry; 1992 Jul; 32(1):72-8. PubMed ID: 1356490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dosage of neuroleptics (author's transl)].
    Haase HJ
    MMW Munch Med Wochenschr; 1980 Dec; 122(50):1808-13. PubMed ID: 6110184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome during abrupt reduction of neuroleptic treatment.
    Spivak B; Weizman A; Wolovick L; Hermesh H; Tyano S; Munitz H
    Acta Psychiatr Scand; 1990 Feb; 81(2):168-9. PubMed ID: 1970216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abrupt versus gradual withdrawal of antiparkinsonians.
    Weiner WJ
    Am J Psychiatry; 1982 Feb; 139(2):256-7. PubMed ID: 6119914
    [No Abstract]   [Full Text] [Related]  

  • 19. [Unwanted drug effects of psychotropic drugs in neurologic practice].
    Schmidt LG; Schüssler G; Linden M; Müller-Oerlinghausen B
    Nervenarzt; 1985 Jan; 56(1):19-24. PubMed ID: 2858064
    [No Abstract]   [Full Text] [Related]  

  • 20. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.